| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.001 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |